WuXi wants to regain client confidence amid claims of IP transfer to Chinese authorities 

WuXi AppTec said it has “un­wa­ver­ing com­mit­ment” to pro­tect­ing its cus­tomer’s in­tel­lec­tu­al prop­er­ty, in the face of al­le­ga­tions it passed a US client’s in­for­ma­tion to Chi­nese au­thor­i­ties.

Al­though the Biose­cure Act “may cre­ate short-term un­cer­tain­ty” for the wider bio­phar­ma in­dus­try, the Shang­hai-head­quar­tered com­pa­ny “re­mains stead­fast in ‘do­ing the right thing and do­ing it right,’” WuXi AppTec CEO Ge Li said in the com­pa­ny’s first-quar­ter earn­ings press re­lease Mon­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.